Evolent Health, Inc. EVH Income Statement

Evolent health, inc. (EVH)

Income statement / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Sep'14	Jun'14
Revenue
Revenue from Contract with Customer, Excluding Assessed Tax
846,383	802,962	732,766	685,105	627,063	547,688	505,653	468,426	434,950	409,232	361,530	310,977	254,188	212,235	192,431	146,327	96,878	50,820	10,414	0	0	0
Expenses
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below)
513,059	470,467	412,671	373,291	327,825	280,494	274,808	273,799	269,352	263,686	229,310	194,095	155,177	120,043	110,900	86,008	57,398	32,649	7,887	0	0	0
Claims expenses
135,774	127,364	109,554	91,897	70,889	52,169	35,177	16,749	0	0	0	0	-	-	-	-	-	-	-	-	-	-
Selling, General and Administrative Expense
257,046	263,501	264,259	254,730	235,418	227,691	213,959	207,646	205,670	208,066	200,630	182,296	160,692	135,470	126,906	107,232	75,286	42,916	13,082	0	0	0
Depreciation, Depletion and Amortization, Nonproduction
60,913	59,599	54,543	49,285	44,515	41,014	38,379	35,249	32,368	27,731	23,760	20,468	17,224	13,855	13,165	10,537	7,166	4,040	984	0	0	0
Gain on disposal of assets
-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill impairment
-	-	-	-	-	-	-	-	-	-	-	-	160,600	160,600	160,600	160,600	0	0	0	0	-	-
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
-3,997	-3,000	-2,400	-4,104	-4,104	-1,304	-1,304	500	400	300	200	0	-	0	0	-	-	-	-	-	-	-
Operating Expenses
1,152,995	908,331	829,027	765,099	674,543	600,064	561,019	533,943	507,790	497,697	451,814	394,773	491,607	429,968	411,571	364,377	139,850	79,605	21,953	0	0	0
Operating loss
-306,612	-105,369	-96,261	-79,994	-47,480	-52,376	-55,366	-65,517	-72,840	-88,465	-90,284	-83,796	-237,419	-217,733	-219,140	-218,050	-42,972	-28,785	-11,539	0	0	0
Interest income
3,987	3,548	3,392	3,428	3,440	3,760	3,203	2,543	1,656	978	822	876	970	0	0	0	-	-	-	-	-	-
Interest expense
14,534	13,735	10,958	8,193	5,484	3,416	3,443	3,535	3,636	3,028	2,148	1,201	247	-67	-13	0	0	67	13	0	0	0
Gain on consolidation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0
Income (Loss) from Equity Method Investments
-9,465	-8,143	-5,665	-5,036	-4,736	-3,020	-2,008	-1,333	-1,755	-1,870	-1,949	-1,363	-841	-462	-14	-16,846	-28,165	-31,332	-37,271	0	0	0
Other income (expense), net
-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	-	-	-
Loss before income taxes and non-controlling interests
-327,116	-123,763	-109,596	-89,234	-54,151	-55,041	-57,464	-67,722	-76,404	-92,318	-93,506	-85,478	-237,533	-217,161	-218,322	179,809	343,289	354,083	365,336	0	0	0
Provision (benefit) for income taxes
-21,536	64	1,048	-459	40	-4,599	-6,448	-7,039	-6,637	-11,149	-9,691	-9,362	-10,755	-7,309	-7,157	22,487	23,475	29,169	29,273	0	0	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
-305,580	-123,827	-110,644	-88,775	-54,191	-50,442	-51,016	-60,683	-69,767	-81,169	-83,815	-76,116	-226,778	-209,852	-211,165	157,322	319,814	324,914	336,063	0	0	0
Net Income (Loss) Attributable to Noncontrolling Interest
-3,609	-3,265	-3,174	-3,004	-1,533	-1,311	-1,726	-4,404	-9,102	-16,257	-20,283	-21,102	-67,036	-63,398	-63,939	-63,751	-12,680	-8,532	-3,424	0	0	0
Net loss attributable to common shareholders of Evolent Health, Inc.
-301,971	-120,562	-107,470	-85,771	-52,658	-49,131	-49,290	-56,279	-60,665	-64,912	-63,532	-55,014	-159,742	-146,454	-147,226	221,073	332,494	333,446	339,487	0	0	0
Basic
-	-	-	-	-	-	-	-	-	0	0	-55,014	-	-146,454	-147,226	220,179	330,310	329,233	334,003	0	0	0
Diluted
-	-	-	-	-	-	-	-	-	0	0	-55,014	-	-154,420	-155,192	209,683	319,814	326,703	331,473	0	0	0
Loss per common share
Basic and diluted (in dollars per share)
-2.40	-0.30	-0.38	-0.59	-0.21	-0.16	-0.13	-0.18	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-0.18	-0.28	-0.34	-	-0.26	-0.20	-2.91	-8.04	-0.29	25.69	-4.22	-2.07	-3.17
Diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-0.18	-0.28	-0.34	-	-0.26	-0.20	-2.91	1.71	-0.29	9.73	-4.22	-2.07	-3.17
Weighted-average common shares outstanding
Weighted Average Number of Shares Outstanding, Basic and Diluted
84,013	83,819	82,289	79,335	78,769	77,999	77,209	75,375	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in shares)
-	-	-	-	-	-	-	-	-	70,328	59,478	52,599	-	43,110	42,594	42,185	42,084	41,468	13,976	2,988	2,506	2,272
Diluted (in shares)
-	-	-	-	-	-	-	-	-	70,328	59,478	52,599	-	43,110	42,594	42,185	103,445	41,468	36,643	2,988	2,506	2,272
Comprehensive loss
Net loss
-305,580	-123,827	-110,644	-88,775	-54,191	-50,442	-51,016	-60,683	-69,767	0	0	0	-	-	-	-	-	-	-	-	-	-
Other comprehensive loss, net of taxes, related to:
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
-52	49	1	-158	-182	-264	-148	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-
Total comprehensive loss
-305,632	-123,778	-110,643	-88,933	-54,373	-50,706	-51,164	-60,683	-69,767	0	0	0	-	-	-	-	-	-	-	-	-	-
Total comprehensive loss attributable to non-controlling interests
-3,609	-3,265	-3,174	-3,004	-1,533	-1,311	-1,726	-4,404	-9,102	0	0	0	-	-	-	-	-	-	-	-	-	-
Total comprehensive loss attributable to common shareholders of Evolent Health, Inc.
-302,023	-120,513	-107,469	-85,929	-52,840	-49,395	-49,438	-56,279	-60,665	0	0	0	-	-	-	-	-	-	-	-	-	-
Transformation services
Revenue from Contract with Customer, Excluding Assessed Tax
15,203	19,447	23,493	29,764	32,916	29,616	28,590	25,736	29,466	35,861	35,414	40,441	38,320	36,679	35,705	28,020	19,906	9,486	2,703	0	0	0
Platform and operations services
Revenue from Contract with Customer, Excluding Assessed Tax
659,438	622,184	568,840	537,664	500,190	449,321	430,935	419,299	405,484	373,371	326,116	270,536	215,868	175,556	156,726	118,307	76,972	41,334	7,711	0	0	0
Premiums
Revenue from Contract with Customer, Excluding Assessed Tax
171,742	161,331	140,433	117,677	93,957	68,751	46,128	23,391	0	0	0	0	-	-	-	-	-	-	-	-	-	-